{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:10:39Z","timestamp":1790413839190,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.avsg.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T06:51:07Z","timestamp":1719384667000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-4777","authenticated-orcid":false,"given":"Reid C.","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"DeLoughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enjae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherene","family":"Shalhub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy K.","family":"Liem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.05.005_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-017-0080-7","article-title":"Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature","volume":"6","author":"Ezekwudo","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.avsg.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/ejh.12921","article-title":"Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia","volume":"99","author":"Davis","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.avsg.2024.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/phar.2298","article-title":"Potential role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia","volume":"39","author":"Barlow","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.avsg.2024.05.005_bib5","series-title":"Diagnosis and Management of Heparin-Induced Thrombocytopenia (HIT) Ash Clinical Practice Guidelines Venous Thromboembolism (VTE) Pocket Guide","author":"Pishko","year":"2018"},{"key":"10.1016\/j.avsg.2024.05.005_bib6","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.jvs.2022.07.087","article-title":"Direct oral anticoagulants versus direct thrombin inhibitors for treatment of acute heparin-induced thrombocytopenia","volume":"76","author":"Pham","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.05.005_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jcpt.13537","article-title":"Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia","volume":"47","author":"Cirbus","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.avsg.2024.05.005_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.avsg.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00068-013-0333-z","article-title":"Dalteparin versus Enoxaparin for the prevention of venous thromboembolic events in trauma patients","volume":"40","author":"Okoye","year":"2014","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.avsg.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/jth.14317","article-title":"Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer","volume":"16","author":"Van Matre","year":"2018","journal-title":"J Thromb Haemostasis"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T22:06:36Z","timestamp":1728511596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":10,"alternative-id":["S0890509624002814"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.005","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-Induced Thrombocytopenia (HIT) in the Direct Oral Anticoagulants (DOAC) Era","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}